127 related articles for article (PubMed ID: 8071314)
1. Removal of zinc is required for processing of the mature nucleocapsid protein of human immunodeficiency virus, type 1, by the viral protease.
Wondrak EM; Sakaguchi K; Rice WG; Kun E; Kimmel AR; Louis JM
J Biol Chem; 1994 Sep; 269(35):21948-50. PubMed ID: 8071314
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles.
Turpin JA; Terpening SJ; Schaeffer CA; Yu G; Glover CJ; Felsted RL; Sausville EA; Rice WG
J Virol; 1996 Sep; 70(9):6180-9. PubMed ID: 8709244
[TBL] [Abstract][Full Text] [Related]
3. The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes.
Rice WG; Schaeffer CA; Graham L; Bu M; McDougal JS; Orloff SL; Villinger F; Young M; Oroszlan S; Fesen MR
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9721-4. PubMed ID: 7692451
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds.
Rice WG; Schaeffer CA; Harten B; Villinger F; South TL; Summers MF; Henderson LE; Bess JW; Arthur LO; McDougal JS
Nature; 1993 Feb; 361(6411):473-5. PubMed ID: 8429889
[TBL] [Abstract][Full Text] [Related]
5. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
Huang M; Maynard A; Turpin JA; Graham L; Janini GM; Covell DG; Rice WG
J Med Chem; 1998 Apr; 41(9):1371-81. PubMed ID: 9554870
[TBL] [Abstract][Full Text] [Related]
6. Specific disulfide formation in the oxidation of HIV-1 zinc finger protein nucleocapsid p7.
Yu X; Hathout Y; Fenselau C; Sowder RC; Henderson LE; Rice WG; Mendeleyev J; Kun E
Chem Res Toxicol; 1995 Jun; 8(4):586-90. PubMed ID: 7548739
[TBL] [Abstract][Full Text] [Related]
7. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.
Dannull J; Surovoy A; Jung G; Moelling K
EMBO J; 1994 Apr; 13(7):1525-33. PubMed ID: 8156990
[TBL] [Abstract][Full Text] [Related]
8. In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence.
Tözsér J; Shulenin S; Louis JM; Copeland TD; Oroszlan S
Biochemistry; 2004 Apr; 43(14):4304-12. PubMed ID: 15065874
[TBL] [Abstract][Full Text] [Related]
9. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
Poon DT; Li G; Aldovini A
J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
[TBL] [Abstract][Full Text] [Related]
10. Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function.
Urbaneja MA; Kane BP; Johnson DG; Gorelick RJ; Henderson LE; Casas-Finet JR
J Mol Biol; 1999 Mar; 287(1):59-75. PubMed ID: 10074407
[TBL] [Abstract][Full Text] [Related]
11. Application of electrospray ionization mass spectrometry for studying human immunodeficiency virus protein complexes.
Loo JA; Holler TP; Foltin SK; McConnell P; Banotai CA; Horne NM; Mueller WT; Stevenson TI; Mack DP
Proteins; 1998; Suppl 2():28-37. PubMed ID: 9849908
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS.
Rice WG; Supko JG; Malspeis L; Buckheit RW; Clanton D; Bu M; Graham L; Schaeffer CA; Turpin JA; Domagala J; Gogliotti R; Bader JP; Halliday SM; Coren L; Sowder RC; Arthur LO; Henderson LE
Science; 1995 Nov; 270(5239):1194-7. PubMed ID: 7502043
[TBL] [Abstract][Full Text] [Related]
13. Zinc binding to the HIV-1 nucleocapsid protein: a thermodynamic investigation by fluorescence spectroscopy.
Mély Y; De Rocquigny H; Morellet N; Roques BP; Gérad D
Biochemistry; 1996 Apr; 35(16):5175-82. PubMed ID: 8611501
[TBL] [Abstract][Full Text] [Related]
14. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
15. The role of nucleocapsid of HIV-1 in virus assembly.
Dawson L; Yu XF
Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
[TBL] [Abstract][Full Text] [Related]
16. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
17. Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteins.
Poljak L; Batson SM; Ficheux D; Roques BP; Darlix JL; Käs E
J Mol Biol; 2003 Jun; 329(3):411-21. PubMed ID: 12767826
[TBL] [Abstract][Full Text] [Related]
18. The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities.
Tummino PJ; Harvey PJ; McQuade T; Domagala J; Gogliotti R; Sanchez J; Song Y; Hupe D
Antimicrob Agents Chemother; 1997 Feb; 41(2):394-400. PubMed ID: 9021197
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins.
Rice WG; Baker DC; Schaeffer CA; Graham L; Bu M; Terpening S; Clanton D; Schultz R; Bader JP; Buckheit RW; Field L; Singh PK; Turpin JA
Antimicrob Agents Chemother; 1997 Feb; 41(2):419-26. PubMed ID: 9021201
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
Berthoux L; Péchoux C; Ottmann M; Morel G; Darlix JL
J Virol; 1997 Sep; 71(9):6973-81. PubMed ID: 9261426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
